Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Europe and Israel or involving organisations from these countries.

Total search results: 6676 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 65 66 67  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
SP Industries–Harbour Group: investment, 201512 acquisition €na by Harbour Group from Graham Partners 2015-12-09
Bridgepoint–Kohlberg Kravis Roberts: investment, 201512 acquisition €na of LGC by KKR from Bridgepoint 2015-12-08
Erytech–SEVERAL: investment, 201512 private placement €25.4m of 940k new ordinary shares at €27/share to qualified Europ + US investors 2015-12-07
Iterum Therapeutics–Pfizer: sulopenem, 201512– license from Pfizer w upfront cash + equity interest plus equity + cash milestones + royalties 2015-12-01
TiGenix–Cormorant Asset Management: investment, 201511 private placement totalling €8.7m incl €4.7m to Cormorant Global Healthcare 2015-11-25
TiGenix–SEVERAL: investment, 201511 private placement €8.7m with 9.1m new shares €0.95/share to Cormorant + European institutional investors 2015-11-25
Regeneron–ERS Genomics: CRISPR technology, 201511– license €na for use in drug discovery + development 2015-11-24
Pfizer–Servier: T-cell immunotherapy, 201511– collab + license agreem for UCART19 in the US 2015-11-19
Ovizio–New Science Ventures: investment, 201511 financing round totalling €8m incl co-lead investor New Science Ventures 2015-11-16
Ovizio–SEVERAL: investment, 201511 financing round €8m co-led by New Science Ventures + a private investor 2015-11-16
14M Genomics–JW Communications: public relations, 201507 service existent by JW Communications 2015-11-12
NightstaRx–JW Communications: public relations, 201511 service existent by JW Communications 2015-11-12
Omeicos–Germany (govt): grant, 201511– BMBF research grant €1.7m 2015-11-02
AxioMx–Abcam: investment, 201511 acquisition $20m upfront + $20.5m milestones 2015-11-01
MTIP MedTech Innovation Partners–SEVERAL: investment, 201511–201604 1st closing CHF30m of 1st MTIP Fund 2015-11-01
Servier–Cellectis: T-cell immunotherapy, 201511– acquisition excl rights to UCART19 by Servier 2015-11-01
Tusk Therapeutics–SEVERAL: investment, 201511 financing round Series A €30m 2015-11-01
Arvinas–SEVERAL: investment, 201510 financing round Series B $41.6m led by RA Capital Management 2015-10-21
Science 37–Novartis: investment, 201510 financing round Series A totalling $6.5m co-led by Lux Capital + dRx Capital 2015-10-20
Science 37–SEVERAL: investment, 201510 financing round Series A $6.5m co-led by Lux Capital + dRx Capital 2015-10-20
Zavante Therapeutics–SEVERAL: investment, 201510 seed financing round 2015-10-09
Acumen Research Labs–Curetis: molecular diagnostics, 201510– distribution excl multi-year of Unyvero product line in ASEAN by Acumen 2015-10-05
Curetis–Acumen Research Labs: molecular diagnostics, 201510– license excl ww AcuSept biomarker panel for joint dev of Unyvero sepsis response test 2015-10-05
Orbit Discovery–Univ Oxford: investment, 201510c seed investor Oxford Sciences Innovation 2015-10-01
Roche–Arvinas: protein degradation drugs, 201510– strategic license multi-year for PROTAC technology to Genentech 2015-10-01
Encycle Therapeutics–BDC Capital: investment, 201509 financing round totalling C$2.85m incl co-investor BDC Capital 2015-09-30
Encycle Therapeutics–Canada (govt): investment, 201509 financing round totalling C$2.85m incl co-investor Accel-Rx Health Sciences Accelerator 2015-09-30
Encycle Therapeutics–Ontario (govt): investment, 201509 financing round totalling C$2.85m incl co-investor MaRS Investment Accelerator Fund 2015-09-30
Encycle Therapeutics–SEVERAL: investment, 201509 financing round C$2.85m led by Takeda Ventures 2015-09-30
Encycle Therapeutics–Takeda: investment, 201509 financing round totalling C$2.85m incl lead investor Takeda Ventures 2015-09-30
Quethera–Midven: investment, 201509 seed financing round with lead investor Rainbow Seed Fund + co-investor Cambridge Enterprise 2015-09-17
Quethera–SEVERAL: investment, 201509 seed financing round with lead investor Rainbow Seed Fund + co-investor Cambridge Enterprise 2015-09-17
Quethera–Univ Cambridge: investment, 201509 seed financing round with lead investor Rainbow Seed Fund + co-investor Cambridge Enterprise 2015-09-17
ReViral–EMS (BR): investment, 201509 financing round Series A totalling $21m incl new + co-investor Brace Pharma Capital 2015-09-08
ReViral–LCF Rothschild: investment, 201509 financing round Series A totalling $21m incl new + co-lead investor EdRIP 2015-09-08
ReViral–OrbiMed: investment, 201509 financing round Series A totalling $21m incl new + co-lead investor Orbimed 2015-09-08
Baxalta–Novimmune: therapeutic antibodies, 201509– collab r+d €na bispecific antibodies for hemophilia A 2015-09-02
Euroscreen–Fund+: investment, 201509 follow-on investment by Fund+ 2015-09-01
Novadip–Fund+: investment, 201508 financing round Series A totalling €28m incl co-investor Fund+ 2015-08-31
Intrexon–SEVERAL: investment, 201508 public offering $230m w 4.878k + 732k shares common stock at $41/share 2015-08-20
CXR Biosciences–Concept Life Sciences: investment, 201508 acquisition of CXR by Concept Life Sciences 2015-08-17
Oxitec–Intrexon: investment, 201508– acquisition $80m cash + $80m common stock of Oxitec Ltd by Intrexon Corp 2015-08-10
Protembis–SEVERAL: investment, 201507 seed financing round 7-digit € incl Innovationsstarter Fonds + Geratherm + angel investors 2015-07-28
DBV Technologies–RooneyPartners: public relations, 201507 service existent by Rooney & Associates 2015-07-20
AdvanDx–OpGen: investment, 201507 merger acquisition by AdvanDx for 682k shares of OpGen common stock 2015-07-14
ViraTherapeutics–Austria (govt): investment, 201506 financing round Series A 1st closing totalling €3.6m incl co-investor aws 2015-06-23
ViraTherapeutics–Boehringer: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
ViraTherapeutics–EMBL: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
Celgene–Bluebird Bio: CAR-T cell therapy, 201506– collab development amended to focus on anti-BCMA CAR-T cell therapies 2015-06-01
Biosyntia–Novo Group: investment, 201505 seed financing round totalling DKK12.5m incl lead investor Novo Seeds 2015-05-21
Biosyntia–SEVERAL: investment, 201505 seed financing round DKK12.5m led by Novo Seeds 2015-05-21
Auspex Pharmaceuticals–Teva: investment, 201505 acquisition cash tender offer $3.5b with $101/share 2015-05-05
Autonomic Technologies–LCF Rothschild: investment, 201505 investment by EdRIP 2015-05-01
Cyclenium–Haplogen: virostatic agents, 201505– collab drug discovery small molecule macroycle inhibitors using CMRT technology 2015-05-01
Euroscreen–Fund+: investment, 201505 investment by Fund+ 2015-05-01
GSK–San Raffaele: gene therapy, 201505 collab existent gene therapy for rare diseases with Telethon + OSRI 2015-05-01
iTeos Therapeutics–Fund+: investment, 201505 investment by Fund+ 2015-05-01
Leo Pharma–Argenx: SIMPLE antibody, 201505– collab r+d + excl ww license option for ARGX-112 program for inflammatory skin disorders 2015-05-01
Orgenesis–Fund+: investment, 201505 investment in MaSTherCell by Fund+ 2015-05-01
Promethera–Fund+: investment, 201505 investment by Fund+ 2015-05-01
Q-Biologicals–Fund+: investment, 201505 investment by Fund+ 2015-05-01
Blueberry Therapeutics–SEVERAL: investment, 201504 financing round $1.75m from UK + Swiss investors 2015-04-08
Zebra Medical Vision–Khosla Ventures: investment, 201504 seed financing round totalling incl $8m lead investor Khosla Ventures 2015-04-06
Zebra Medical Vision–SEVERAL: investment, 201504 seed financing round $8m led by Khosla Ventures 2015-04-06
HiberGene–SEVERAL: investment, 201504–201704 financing round Series B €6.7m led by Cantor Fitzgerald 2015-04-01
Premaitha–Illumina: molecular diagnostics, 201809– license agreem as part of settlement incl Premaitha to developm IONA MDx test for Illumina systems 2015-03-16
Macrolide–Bertarelli Group: investment, 201503 financing round Series A totalling $22m inc co-lead investor Gurnet Point Capital 2015-03-04
Macrolide–GSK: investment, 201503 financing round Series A totalling $22m inc co-lead investor SROne 2015-03-04
Macrolide–Novartis: investment, 201503 financing round Series A totalling $22m inc co-lead investor Novartis Venture Fund 2015-03-04
Macrolide–Roche: investment, 201503 financing round Series A totalling $22m inc co-lead investor Roche Ventures 2015-03-04
Macrolide–SEVERAL: investment, 201503 financing round Series A $22m led by NVF + Gurnet Point + Roche Ventures + SR One 2015-03-04
OpGen–SEVERAL: investment, 201503–201505 IPO $17.1m+$2.565m with 2.85m+427.5k units consisting of 1 share + 1 warrant at $6/unit 2015-03-03
Genenta Science–SEVERAL: investment, 201503 financing round Series A €10m 2015-03-01
Synthace–SEVERAL: investment, 201502 financing round £2.2m incl SOSventures + Bioeconomy Capital et al 2015-02-11
G1 Therapeutics–SEVERAL: investment, 201502 financing round Series B $33m co-led by Eshelman Ventures + RA Capital Management 2015-02-05
HiberGene–SEVERAL: investment, 201502 financing round Series A €2m 2015-02-01
R2R Biofluidics project–EU (govt): grant, 201502–201901 H2020 grant €6.4m out of total budget of €7.9m 2015-02-01
Boehringer–Vanderbilt Univ: Ras inhibitors, 201703– collab expansion r+d small-molecule KRAS inhibitors for cancer 2015-01-13
Fluidic Analytics–SEVERAL: investment, 201501 financing round Series A £1.56m ($2.4m) led by Cambridge Enterprise 2015-01-12
Alcobra–LifeSci: public relations, 201501 service existent US investor relations by LifeSci Advisors 2015-01-09
Alcobra–Sam Brown: public relations, 201501 service existent by Sam Brown Inc 2015-01-09
Baxalta–Symphogen: cancer immunotherapy, 201601– collab strategic ww €160m upfront + €1.4b milestones + roaylties in immuno-oncology 2015-01-04
Aquila Biolabs–SEVERAL: investment, 2015 seed financing round 7-digit € 2015-01-01
Atomwise–SEVERAL: investment, 2015 seed financing round incl Y Combinator + Khosla Ventures + DJF 2015-01-01
BIO (US)–Inova Software: business partnering software, 2015– collab using One-on-One for BIO Annual Convention 2015-01-01
Biocentric–Hain Lifescience: investment, 2015 acquisition of Biocentric by Hain 2015-01-01
Boston Biotech Conference–Informa: investment, 2015 acquisition 100% £12.7m in cash net of cash acquired 2015-01-01
ClinicPoint–SEVERAL: investment, 2015 funding €1m total private investment attracted over the year 2015 2015-01-01
Corvidia Therapeutics–Sofinnova: investment, 2015 seed financing from Sofinnova Partners 2015-01-01
Enyo Pharma–SEVERAL: investment, 2015 seed financing round €2.2m 2015-01-01
Galgo Medical–SEVERAL: investment, 2015 funding €1m total private investment attracted over the year 2015 2015-01-01
Gemedica Therapeutics–SEVERAL: investment, 2015 funding €2.5m total private investment attracted over the year 2015 2015-01-01
Greenaltech–SEVERAL: investment, 2015 funding €2m total private investment attracted over the year 2015 2015-01-01
GreenBone–SEVERAL: investment, 2015 seed financing round €3m from ZernikeMeta Ventures + Italian Angels for Growth + private investors 2015-01-01
IFM Therapeutics–Atlas Venture: investment, 2015 seed funding by Atlas Venture 2015-01-01
iSalud–SEVERAL: investment, 2015 funding €1m total private investment attracted over the year 2015 2015-01-01
Jecure Therapeutics–Versant Ventures: investment, 2015 seed financing from founding investor Versant Ventures 2015-01-01
KBI BioPharma–JSR Corp: investment, 2015 acquisition of KBI BioPharma Inc by JSR Corp 2015-01-01
KSQ Therapeutics–Alexandria Real Estate: investment, 2015–201710 financing totalling $76m incl co-investor Alexandria Equities 2015-01-01
KSQ Therapeutics–ARCH Venture: investment, 2015–201710 financing totalling $76m incl co-investor ARCH Venture Partners 2015-01-01
next pagenext page 1 2 3 ... 65 66 67  next pagenext page



Advertisement

Picture [iito] Made Without Love 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Lee Hood Speaking 650x300px

» top